Volume 17, Issue 3 pp. 209-217

Additional Treatment Services in a Cocaine Treatment Study: Level of Services Obtained and Impact on Outcome

Matthew Worley BA

Matthew Worley BA

Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania

Search for more papers by this author
Robert Gallop PhD

Robert Gallop PhD

Department of Mathematics, West Chester University, West Chester, Pennsylvania

Search for more papers by this author
Mary Beth Connolly Gibbons PhD

Mary Beth Connolly Gibbons PhD

Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania

Search for more papers by this author
Sarah Ring-Kurtz MS

Sarah Ring-Kurtz MS

Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania

Search for more papers by this author
Julie Present BA

Julie Present BA

Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania

Search for more papers by this author
Roger D. Weiss MD

Roger D. Weiss MD

McLean Hospital and Department of Psychiatry, Harvard Medical School, Boston, Massachusetts

Search for more papers by this author
Paul Crits-Christoph PhD

Corresponding Author

Paul Crits-Christoph PhD

Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania

Room 650, 3535 Market St., Philadelphia, PA, 19104. E-mail: [email protected]Search for more papers by this author
First published: 18 February 2010
Citations: 4

Abstract

The objective of this study was to examine the level of additional treatment services obtained by patients enrolled in the NIDA Cocaine Collaborative Study, a multi-center efficacy trial of four treatments for cocaine dependence, and to determine whether these services impact treatment outcome. Cocaine-dependent patients (N = 487) were recruited at five sites and randomly assigned to six months of one of four psychosocial treatments. Assessments were made at baseline, monthly during treatment, and at follow-ups at 9, 12, 15, and 18 months post-randomization. On average, patients received little or no additional treatment services during active treatment (first six months), but the rate of obtaining most services increased during the follow-up phase (month 7 to 18). In general, the treatment groups did not differ in the rates of obtaining non-protocol services. For all treatment groups, patients with greater psychiatric severity received more medical and psychiatric services during active treatment and follow-up. Use of treatment services was unrelated to drug use outcomes during active treatment. However, during the follow-up period, increased use of psychiatric medication, twelve-step attendance, and twelve-step participation was related to less drug use. The results suggest that during uncontrolled follow-up phases, additional non-protocol services may potentially confound the interpretation of treatment group comparisons in drug use outcomes.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.